Healthcare and life sciences decision making increasingly relies on multimodal data to diagnose diseases, prescribe medicine and predict treatment outcomes, develop and optimize innovative therapies accurately. Traditional approaches analyze fragmented data, such as ‘omics for drug discovery, medical images for diagnostics, clinical trial reports for validation, and electronic health records (EHR) for patient treatment. As a result, decision makers (CxOs, VPs, Directors) often miss critical insights hidden in the relationships between data types. Recent advancements in AI enable you to integrate and analyze these fragmented data streams efficiently to support a more complete understanding of therapeutics and patient care.
AWS provides a unified environment for multimodal biological foundation models (BioFMs), enabling you to make more confident, timely decision-making in personalized medicine. This AI system combines biological data, model development, scalable…
